Related Experiment Video
Updated: Aug 19, 2025
09:20
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
3.7K
Lumican modulates adipocyte function in obesity-associated type 2 diabetes
Clarissa Strieder-Barboza1,2,3, Carmen G Flesher1, Lynn M Geletka4
1Department of Surgery , University of Michigan Medical School, MI, USA.
Adipocyte
|December 2, 2022
Summary
Lumican, a protein linked to obesity, worsens type 2 diabetes by impairing fat cell function and insulin sensitivity. Targeting lumican may offer new treatments for diabetes-related metabolic dysfunction.
Area of Science:
- Metabolic research
- Endocrinology
- Adipose tissue biology
Background:
- Obesity and type 2 diabetes (DM) are linked to adipose tissue dysfunction.
- Lumican, a proteoglycan, is implicated in obesity, insulin resistance (IR), and adipocyte dysfunction.
Purpose of the Study:
- To investigate the role of lumican in human visceral adipose tissue (VAT) dysfunction in type 2 diabetes.
- To determine the effects of lumican on adipocyte metabolism, lipolysis, adipogenesis, and insulin sensitivity.
Main Methods:
- Analysis of lumican expression in human VAT and adipocytes from subjects with and without DM.
- Lumican knockdown experiments in adipocytes.
- Treatment of adipocytes with recombinant human lumican.
- Assessment of lipolysis, adipogenesis, and insulin sensitivity.
- Investigation of the involvement of ERK signaling pathway.
Main Results:
- Lumican expression was elevated in VAT and adipocytes of individuals with DM.
- Lumican knockdown in diabetic adipocytes improved adipogenesis and insulin sensitivity while decreasing lipolysis.
- Recombinant lumican treatment increased lipolysis and impaired insulin sensitivity in a manner dependent on ERK signaling.
Conclusions:
- Lumican impairs adipocyte metabolism in type 2 diabetes, partly through ERK signaling.
- Lumican represents a potential therapeutic target for adipose tissue-targeted treatments in DM.
More Related Videos
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
2.3K
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
15.2K
Related Concept Videos
01:24Glucagon-like Receptor Agonists
383
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
383
01:24Obesity
579
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
579
01:36Carbohydrate Metabolism
11.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.4K
01:30Regulation of Food Intake
319
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
319
01:22Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
01:23Dipeptidyl Peptidase 4 Inhibitors
230
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
230